Medicine · 2024
The causal association of smoking, alcohol intake, and coffee intake with the risk of bacterial pneumonia: A Mendelian randomization study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
He Zhendong, Zheng Leting, Chen Zhanrui, Wen Jing, Qin Fang, Mo Hanyou
Аннотация
BACKGROUND: At present, the association of smoking, alcohol intake, and coffee intake with the risk of bacterial pneumonia (BP) remains controversial. In this study, we used a 2-sample Mendelian randomization (MR) analysis to estimate the association of smoking, alcohol intake, and coffee intake with the risk of BP.
METHODS: We extracted genetic variants associated with smoking initiation and cigarettes per day from the Genome-Wide Association Study and Sequencing Consortium of Alcohol and Nicotine Use database (944,625 individuals). We also extracted genetic variants associated with past tobacco smoking, alcohol intake frequency, and coffee intake from the UK Biobank database (1,316,166 individuals). BP outcomes were chosen from the FinnGen genome-wide association studies (GWAS) database (7987 patients and 188,868 controls). The inverse variance-weighted method was used primarily to calculate odds ratios (OR) and 95% confidence intervals (CI). Sensitivity analysis using different approaches such as weighted median, MR Egger, and MR pleiotropy residual sum and outlier (MR-PRESSO) have been implemented, as well as leave-one-out analysis to identify pleiotropy.
RESULTS: The 2-sample MR analysis supported the causal association of genetically predicted cigarettes per day (OR: 1.23, 95% CI: [1.08-1.39], P < .01] and smoking initiation (OR: 1.22, 95% CI: [1.03-1.44], P = .02) with the risk of BP, but not past tobacco smoking, alcohol intake frequency, and coffee intake. Heterogeneity (P > .05) and pleiotropy (P > .05) tests provided confirmatory evidence for the validity of our MR estimates.
CONCLUSION: Our findings provide relevant evidence for a favorable causal association of genetically predicted smoking initiation and cigarettes per day with BP risk. However, there may not be a causal association between past tobacco smoking, alcohol intake, and coffee intake with increased BP incidence rates.
METHODS: We extracted genetic variants associated with smoking initiation and cigarettes per day from the Genome-Wide Association Study and Sequencing Consortium of Alcohol and Nicotine Use database (944,625 individuals). We also extracted genetic variants associated with past tobacco smoking, alcohol intake frequency, and coffee intake from the UK Biobank database (1,316,166 individuals). BP outcomes were chosen from the FinnGen genome-wide association studies (GWAS) database (7987 patients and 188,868 controls). The inverse variance-weighted method was used primarily to calculate odds ratios (OR) and 95% confidence intervals (CI). Sensitivity analysis using different approaches such as weighted median, MR Egger, and MR pleiotropy residual sum and outlier (MR-PRESSO) have been implemented, as well as leave-one-out analysis to identify pleiotropy.
RESULTS: The 2-sample MR analysis supported the causal association of genetically predicted cigarettes per day (OR: 1.23, 95% CI: [1.08-1.39], P < .01] and smoking initiation (OR: 1.22, 95% CI: [1.03-1.44], P = .02) with the risk of BP, but not past tobacco smoking, alcohol intake frequency, and coffee intake. Heterogeneity (P > .05) and pleiotropy (P > .05) tests provided confirmatory evidence for the validity of our MR estimates.
CONCLUSION: Our findings provide relevant evidence for a favorable causal association of genetically predicted smoking initiation and cigarettes per day with BP risk. However, there may not be a causal association between past tobacco smoking, alcohol intake, and coffee intake with increased BP incidence rates.